Increased Blood Carboxyhaemoglobin Concentrations in Inflammatory Pulmonary Diseases
Overview
Affiliations
Background: Exhaled carbon monoxide has been reported to increase in inflammatory pulmonary diseases and to be correlated with blood carboxyhaemoglobin (Hb-CO) concentration. A study was undertaken to determine whether arterial blood Hb-CO increases in patients with inflammatory pulmonary diseases.
Methods: The Hb-CO concentration in arterial blood was measured with a spectrophotometer in 34 normal control subjects, 24 patients with bronchial asthma, 52 patients with pneumonia, and 21 patients with idiopathic pulmonary fibrosis (IPF).
Results: The mean (SE) Hb-CO concentrations in patients with bronchial asthma during exacerbations (n=24, 1.05 (0.05)%), with pneumonia at the onset of illness (n=52, 1.08 (0.06)%), and with IPF (n=21, 1.03 (0.09)%) were significantly higher than those in control subjects (n=34, 0.60 (0.07)%) (mean difference 0.45% (95% confidence interval (CI) 0.23 to 0.67), p<0.01 in patients with bronchial asthma, mean difference 0.48% (95% CI 0.35 to 0.60), p<0.0001 in patients with pneumonia, and mean difference 0.43% (95% CI 0.26 to 0.61) p<0.001 in patients with IPF). In 20 patients with bronchial asthma the Hb-CO concentration decreased after 3 weeks of treatment with oral glucocorticoids (p<0.001). In 20 patients with pneumonia the Hb-CO concentration had decreased after 3 weeks when patients showed evidence of clinical improvement (p<0.001). The values of C-reactive protein (CRP), an acute phase protein, correlated with Hb-CO concentrations in patients with pneumonia (r=0.74, p<0.0001) and in those with IPF (r=0.46, p<0.01). In patients with bronchial asthma changes in Hb-CO concentrations were significantly correlated with those in forced expiratory volume in 1 second (FEV(1)) after 3 weeks (r=0.67, p<0.01). Exhaled carbon monoxide (CO) concentrations were correlated with Hb-CO concentrations (n=33, r=0.80, p<0.0001).
Conclusions: Hb-CO concentrations are increased in inflammatory pulmonary diseases including bronchial asthma, pneumonia, and IPF. Measurement of arterial Hb-CO may be a useful means of monitoring pulmonary inflammation.
Meservey A, Krishnan G, Green C, Morrison S, Rackley C, Kraft B Crit Care Explor. 2023; 5(8):e0957.
PMID: 37614802 PMC: 10443764. DOI: 10.1097/CCE.0000000000000957.
Khan U, Dhar A, Mantoo S, Shah T, Rathod S Cureus. 2022; 14(11):e31955.
PMID: 36582556 PMC: 9795327. DOI: 10.7759/cureus.31955.
Prognostic value of carboxyhemoglobin in pediatric intensive care unit.
Alakaya M, Arslankoylu A Pak J Med Sci. 2022; 38(7):1911-1917.
PMID: 36246687 PMC: 9532639. DOI: 10.12669/pjms.38.7.5753.
Izhakian S, Harper E, Gorelik O, Frajman A, Mekiten O, Bar-Chaim A Can Respir J. 2022; 2022:6689805.
PMID: 35469243 PMC: 9034945. DOI: 10.1155/2022/6689805.
Carboxyhemoglobinemia in Critically Ill Coronavirus Disease 2019 Patients.
Faisal H, Ali S, Xu J, Nisar T, Sabawi M, Salazar E J Clin Med. 2021; 10(12).
PMID: 34205655 PMC: 8234747. DOI: 10.3390/jcm10122731.